ZNTL - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences | Benzinga
NEW YORK and SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that Zentalis management will participate in several upcoming investor conferences:
- TD Cowen 43rd Annual Health Care Conference
- Location: Boston, MA
- Event: Gynecological Cancers Corporate Panel Discussion
- Date and Time: March 5 at 10:30 a.m. ET
- Leerink Partners Global Biopharma Conference
- Location: Miami, FL
- Event: Fireside discussion
- Date and Time: March 11 at 3:20 p.m. ET
- Jefferies Biotech on the Bay Summit
- Location: Miami, FL
- Event: Investor meetings ...